• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Accel Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
517494
INE258C01038
7.9524585
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
10.96
72.67
EPS(TTM)
Face Value()
Div & Yield %
1.14
2
0
 

Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter
May 12,2026

Total operating expenditure for the period under review was Rs 1,228.66 crore, up 4.5% YoY.

Profit before tax in Q4 FY26 stood at Rs 531.23 crore, up by 10.1% from Rs 482.71 crore in Q4 FY25.

For FY26, the company has recorded net profit and revenue from operations of Rs 1552.02 crore (up 9.7% YoY) and Rs 6,929.05 crore (up 8.1% YoY), respectively.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

The scrip fell 1.99% to currently trade at Rs 27224.40 on the BSE.